PharmaTrain (Pharmaceutical Medicines Training Programme) is the European platform for postgraduate training in Medicines Development and fosters the training needs and quality for all professionals in this field. The main objective of PharmaTrain is to bring newly created as well as longer existing Diploma (Base) Courses, Master Programmes and CPD courses to a European quality level. Such high-level training, based on the achieved PharmaTrain Shared Standards in Medicines Development in Europe, will make the drug development process faster, more economical, more tailored to patients’ needs, and will give Europe a global advantage in developing new innovative medicines. The development of e-learning products supports this objective.
PharmaTrain is one of the 15 projects belonging to the first call of the Innovative Medicines Initiative IMI launched in 2008. The consortium includes 22 Universities and 11 Learned Societies (33 public partners), 15 EFPIA private partners and 3 Advisors. The project started on May 1, 2009 and is funded for five years.
The Innovative Medicines Initiative (IMI) is Europe’s largest public-private partnership aiming to improve the drug development process by supporting a more efficient discovery and development of better and safer medicines for patients. With a €2 billion euro budget, IMI supports collaborative research projects and builds networks of experts from industry, academia, SMEs, patient organisations and regulatory authorities in Europe that will boost innovation in healthcare.
IMI supports research projects in the areas of safety and efficacy, knowledge management and education and training. Projects are selected through open Calls for proposals.
Main office in Brussels:
Square de Meeûs – Rue de l’Industrie 4
BE-1000 Brussels, Belgium
University Basel, ECPM
Phone: +41 61 267 19 44 / 19 50
Fax: +41 61 267 19 48
Mobile: +32 4184.108.40.206.